Wire Stories

Category Added in a WPeMatico Campaign

news_6

Marius Pharmaceuticals Submits New Drug Application to U.S. FDA for Next-Generation Oral Testosterone Replacement Therapy in Male Patients With Hypogonadism

KYZATREX® NDA includes data demonstrating less than 2 mm Hg mean SBP increase as measured by Ambulatory Blood Pressure Monitoring...